BMS-919373

CAS No. 1272353-82-8

BMS-919373( BMS919373 )

Catalog No. M11139 CAS No. 1272353-82-8

BMS-919373 is a potent I(Kur)/Kv1.5 channel blocker with IC50 of 50 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 536 Get Quote
5MG 873 Get Quote
10MG 1161 Get Quote
25MG 1755 Get Quote
50MG 2358 Get Quote
100MG 3177 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    BMS-919373
  • Note
    Research use only, not for human use.
  • Brief Description
    BMS-919373 is a potent I(Kur)/Kv1.5 channel blocker with IC50 of 50 nM.
  • Description
    BMS-919373 is a potent I(Kur)/Kv1.5 channel blocker with IC50 of 50 nM, with selectivity versus hERG, Na, Ca channels and reduced the level of brain penetration; shows robust anti- arrhythmia effects in rabbit and canine pharmacodynamic models and an acceptable cross-species pharmacokinetic profile.Heart Arrhythmia Phase 1 Discontinued.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    BMS919373
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    Potassium Channel
  • Recptor
    Potassium Channel
  • Research Area
    Cardiovascular Disease
  • Indication
    Heart Arrhythmia

Chemical Information

  • CAS Number
    1272353-82-8
  • Formula Weight
    468.535
  • Molecular Formula
    C25H20N6O2S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C1=CC=C(C=C1)C2=C3C(=CC=C2)N=C(N=C3NCC4=CC=CC=N4)C5=CC(=CN=C5)S(=O)(=O)N
  • Chemical Name
    5-(5-phenyl-4-((pyridin-2-ylmethyl)amino)quinazolin-2-yl)pyridine-3-sulfonamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Gunaga P, et al. J Med Chem. 2017 May 11;60(9):3795-3803.
molnova catalog
related products
  • VU0134992 hydrochlor...

    VU0134992 hydrochloride is the first subtype-preferring, orally active and selective blocker of Kir4.1 potassium channel pore(IC50 : 0.97 μM).

  • Repaglinide

    Repaglinide is an oral antihyperglycemic agent used for the treatment of non-insulin-dependent diabetes mellitus (NIDDM).

  • NS 1619

    NS1619 have been reported to have cardio-protective effects after ischemic-reperfusion injury.